Corpus Intelligence IC Memo — FOOTHILL REG MEDICAL CENTER 2026-04-26 14:21 UTC
IC Memo — FOOTHILL REG MEDICAL CENTER
Investment Committee Memorandum | CA | 111 beds | Grade D | EBITDA uplift $6.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FOOTHILL REG MEDICAL CENTER

CCN 050780 | ORANGE, CA | 111 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

FOOTHILL REG MEDICAL CENTER is a 111-bed under-performing / distressed in ORANGE, CA with $88.7M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 31.5% Medicare, 19.2% Medicaid, and 49.2% commercial.

Thesis: Undervalued. Our ML models identify $6.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -93.3% (+736bps).

Net Revenue HCRIS$88.7M
Current EBITDA COMPUTED$-89.3M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS32.1%
Revenue / Bed COMPUTED$799K
Net-to-Gross HCRIS21.0%
Distress Probability ML55.8%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
179
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -100.0% places it below the state median. Among 179 size-comparable peers (56-222 beds), the median margin is -4.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (56-222), prioritizing same-state peers. 179 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FOOTHILL REG MEDICAL CENTER (Target)CA111$88.7M-100.0%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
KFH - MANTECACA213$796.8M15.2%
CHILDRENS HOSP & RES CNTR OAKLCA155$687.9M-7.1%
KFH - WALNUT CREEKCA219$681.0M-3.4%
NORTHBAY HOSPITAL GROUPCA204$676.6M-8.2%
KFH - SAN LEANDROCA216$663.8M10.3%
CONTRA COSTA REGIONAL MEDICAL CA124$595.0M-29.2%
KFH - VALLEJOCA184$531.7M0.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.9M+210bp18mo
Cost to Collect4.5%2.5%$1.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.1M+122bp9mo
Clean Claim Rate88.0%96.0%$57K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.9M
Cost to Collect
$1.8M
Denial Rate Reduction
$1.8M
A/R Days Reduction
$1.1M
Clean Claim Rate
$57K
Total EBITDA Uplift$6.5M
Current EBITDA$-89.3M
+ RCM Uplift+$6.5M
Pro Forma EBITDA$-82.7M
Current Margin-100.0%
Pro Forma Margin-93.3%
WC Released (1x)$3.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-137.3M$-523.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-137.3M$-620.5M0.00x-100.0%
Bull Case9.0x11.0x$-123.6M$-643.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-123.6M$-738.6M0.00x-100.0%
Bear Case11.0x10.0x$-151.1M$-511.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-151.1M$-611.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 32.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 179 hospitals with 56-222 beds
  • Same-state prioritization (n=180)
  • Comp margins: P25=-20.3% / P50=-4.5% / P75=4.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.